U.S. Food and Drug Administration

 

 

 

Press Releases from the Food and Drug Administration
3/27/20 FDA takes action to help increase U.S. supply of ventilators and respirators for protection of healthcare workers, patients
3/28/20 FDA takes further steps to help mitigate supply interruptions of food and medical products
3/30/20 FDA expedites review of diagnostic tests to combat COVID-19

4/03/20 Coronavirus (COVID-19) Update: FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19

4/06/20 Webinar - Enforcement Policy for Personal Protective Equipment (PPE) During COVID-19: Immediately in Effect Guidance

4/07/20 Coronavirus (COVID-19) Update: Serological Tests

4/08/20 Coronavirus (COVID-19) Update: FDA Warns Seller Marketing Dangerous Chlorine Dioxide Products that Claim to Treat or Prevent COVID-19

4/10/20 FDA Authorizes Blood Purification Device to Treat COVID-19

4/10/20 FDA Issues Second Emergency Use Authorization to Decontaminate N95 Respirators

4/12/20 FDA Issues Emergency Use Authorization to Decontaminate Millions of N95 Respirators

4/16/20 FDA Encourages Recovered Patients to Donate Plasma for Development of Blood-Related Therapies

4/16/20 Release of U.S. Government Action Plan To Support the International Response to COVID-19
4/18/20 Coronavirus (COVID-19) Update: Serological Test Validation and Education Efforts
4/21/20 FDA Authorizes First Test for Patient At-Home Sample Collection

4/24/20 FDA Reiterates Importance of Close Patient Supervision for ‘Off-Label’ Use of Antimalarial Drugs to Mitigate Known Risks, Including Heart Rhythm Problems
4/27/20 FDA Continues to Ensure Availability of Alcohol-Based Hand Sanitizer During the COVID-19 Pandemic, Addresses Safety Concerns

5/01/20 FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment
5/07/20 FDA Continues to Combat Fraudulent COVID-19 Medical Products

5/14/20 Federal judge enters temporary injunction against Xephyr LLC doing business as N-Ergetics, preventing sale of Colloidal Silver Products for COVID-19
5/16/20 FDA Authorizes First Standalone At-Home Sample Collection Kit That Can Be Used With Certain Authorized Tests
5/19/20 FDA Collaborations Promote Rigorous Analyses of Real-World Data to Inform Pandemic Response

5/19/20 USDA, FDA Strengthen U.S. Food Supply Chain Protections
5/21/20 FDA Provides Promised Transparency for Antibody Tests
5/29/20 FDA Takes Steps to Streamline Development of Tests With At-Home Sample Collection
6/01/20 FDA Takes Action to Protect Public Health; Increase Supply of Alcohol-Based Hand Sanitizer
6/15/20 FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine

6/15/20 FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of a COVID-19 Treatment Authorized for Emergency Use
6/15/20 FDA Revokes Emergency Use Authorization for Chembio Antibody Test
6/18/20  FDA Takes Additional Action to Harness Real-World Data to Inform COVID-19 Response Efforts

6/24/20 Joint Statement from USDA and FDA on Food Export Restrictions Pertaining to COVID-19
6/30/20 FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines
7/02/20 FDA Authorizes Additional COVID-19 Combination Diagnostic Test Ahead of Flu Season
 

 

 

For the most up-to-date information from the FDA click here to visit their official page.